Which medication is NOT listed as usable with a mucosal atomizer device (MAD)?

Which medication is NOT listed as usable with a mucosal atomizer device (MAD)?

• A. Fentanyl
• B. Ketamine
• C. Midazolam
• D. Morphine Sulfate

Answer: (D)

Mucosal atomization devices deliver medication as a fine spray across the nasal mucosa to achieve rapid, noninvasive absorption through a highly vascular surface, providing quick onset without needing IV access. Medications that are commonly usable with this route include fentanyl, ketamine, and midazolam because they have suitable potency, onset, and formulations that work well when sprayed intranasally. Fentanyl is favored for intranasal use because its high potency means a small volume delivers effective analgesia, and it absorbs reliably through the nasal mucosa. Ketamine also works well intranasally for analgesia or sedation, offering rapid onset and a favorable safety profile in non-injectable administration. Midazolam is used intranasally for rapid sedation or seizure control, again with quick onset and the practicality of avoiding IV access. Morphine sulfate, however, is not listed for use with a mucosal atomizer device. Its nasal bioavailability is variable and generally poorer, leading to slower, less predictable analgesia. The formulation typically used for morphine is not designed for intranasal delivery via MAD, which is why it isn’t included among the usable medications for this route.

Mucosal atomization devices deliver medication as a fine spray across the nasal mucosa to achieve rapid, noninvasive absorption through a highly vascular surface, providing quick onset without needing IV access. Medications that are commonly usable with this route include fentanyl, ketamine, and midazolam because they have suitable potency, onset, and formulations that work well when sprayed intranasally.

Fentanyl is favored for intranasal use because its high potency means a small volume delivers effective analgesia, and it absorbs reliably through the nasal mucosa. Ketamine also works well intranasally for analgesia or sedation, offering rapid onset and a favorable safety profile in non-injectable administration. Midazolam is used intranasally for rapid sedation or seizure control, again with quick onset and the practicality of avoiding IV access.

Morphine sulfate, however, is not listed for use with a mucosal atomizer device. Its nasal bioavailability is variable and generally poorer, leading to slower, less predictable analgesia. The formulation typically used for morphine is not designed for intranasal delivery via MAD, which is why it isn’t included among the usable medications for this route.